|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/6886 | |
| C12Q 1/6897 |
| (11) | Patento numeris | 3172340 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15824252.9 |
| Europos patento paraiškos padavimo data | 2015-07-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-05-31 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-02-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IL2015/050746 |
| Data | 2015-07-20 |
| (87) | Numeris | WO 2016/013007 |
| Data | 2016-01-28 |
| (30) | Numeris | Data | Šalis |
| 201462026715 P | 2014-07-21 | US |
| (72) |
TARCIC, Gabi, IL
ALTSCHULER, Yoram, IL
|
| (73) |
Novellusdx Ltd.,
Bio-Park Hadasah Medical Center Campus P.O.B 12057, 91120 Jerusalem,
IL
|
| (54) | METHODS FOR DETERMINING DRUG RESPONSE OF PATIENT SPECIFIC MUTATIONS |
| METHODS FOR DETERMINING DRUG RESPONSE OF PATIENT SPECIFIC MUTATIONS |